• Develop BIO regulatory policy initiatives related to Drug and Biologic Development for modernization, and International Harmonization of Regulatory Requirements to advance biomedical innovation.• Lead in policy development in diverse portfolio spanning manufacturing, rare disease drug development, biosimilars, and support on clinical trial diversity committees.• Coordinating biotech committee members to develop consensus BIO policies and draft position papers.• Developing and facilitating approval of written BIO responses to the docket, and verbally communicating BIO positions to relevant government officials.• Monitoring new FDA regulations and guidance documents of importance to BIO’s healthcare-focused initiatives• Serve as a BIO contact to the government agencies, including organizing and moderating FDA liaison meetings on behalf of BIO members, as well as attend meetings held by federal agencies or hearings on the Hill.• Engage and convene with key external stakeholders, including trade associations, think tanks, advocacyorganizations, professional societies, and public-private partnerships.• Present at internal and external meetings, workshops, and conferences; e.g. NIH, FDA, NASEM, W.H.O. events• Conduct research into scientific, regulatory, and legislative issues and disseminating relevant information

• Managed multi-sector committees of Cardiac, Immunotox, & Genetic Toxicology with 150 members each• Provided scientific and strategic management to support committee involving academic, government,nonprofit, and private sector subject matter experts.• Collaborated with committee members to design and execute novel scientific research programs, newtool and methods assay, publications, workshops, and trainings.• Managed yearly committee budgets, assisted with communications supports membership development, facilitated workshops and meetings, and contributed to overall HESI strategy and outreach.• Moderator and speaker at internal and external conferences, e.g. HESI annual meeting and SOT, as well as AAI.• Fostered new member engagement and sponsors contributions, as well as new partner collaborations for in-kind study services; amounting to approx. $250K and $1million in a year.• Participated in Board meetings and outreach activities, including Emerging Issues & Academic Outreach Initiatives.• Developed and managed awarded grants, government agency contracts, and FDA PPP proposals.• Established new HESI education outreach and awards programs for over committees.

• Advise and provide high-level deliverables for philanthropists and non-profit foundations on strategic planning and investment of their capital in various biomedical fields• Manage pre- and post-award monitoring activities, including RFP development, reviewer process, executed agreements, and reviewing progress and budget reports• Support due-diligence efforts for various biomedical projects in the fields of neurology, rare diseases, and gene-editing drug discovery, as well as managing team members’ tasks• Lead key portions of state-of-the-science and system analysis, including; landscaping the latest scientific research, industry pipelines, and key stakeholders in the field• Conduct key opinion leader interviews for respective project analysis• Develop scientific retreats and conference sessions to convene key opinion leaders in respective project fields, as well as moderating and speaking at such events• Synthesize complex scientific materials for broad and lay audiences

• Developed interactive STEM lesson plans for third graders in after school programs, which involved managing and coordinating groups of volunteers• Organized weekly events with the YMCA and STEM educational organizations and compiled resources and materials from pharmaceutical companies • Conducted an annual progress report and procured a grant renewal

• Developed forward-looking recommendations for policies and guidance with the CEO of Strong Memorial Hospital, deans, and other faculty members aimed at promoting a diverse and inclusive environment for students, staff, and patients at the medical center• Reviewed institutional policies, such as recruitment plans to increase diverse student bodies and faculty • Reviewed mandatory diversity and inclusion annual reports for the medical center

• Awarded the NIH Pre-doctoral F31 Grant ($132,000) for thesis research on how environmental toxicants contribute to immune dysregulation and the obesity epidemic• Procured $1 million for a pre-clinical novel therapeutic drug development• Selected as Editor’s Highlight and journal cover for Toxicological Sciences• Established scientific blog series, focused on career development and various scientific topics; supported by the Broadening Experience in Scientific Training (BEST) program• Lectured for Life Science Learning Center on microbiology and vaccine development• Developed projects across 3 departments and 2 institutions• Supervised and mentored two graduate researchers and one post-baccalaureate student